Business Description

Description
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 12.57
Equity-to-Asset 0.46
Debt-to-Equity 0.07
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -23.58
Distress
Grey
Safe
Beneish M-Score -5.43
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
12-1 Month Momentum % -16.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.75
Quick Ratio 1.75
Cash Ratio 0.77
Days Inventory 435.01
Days Sales Outstanding 266.89
Days Payable 632.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.1
Shareholder Yield % -3.52

Financials

PMXSF's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:PMXSF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Syntara Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.009
EPS (TTM) ($) -0.011
Beta 0
Volatility % 16.13
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0.026
12-1 Month Momentum % -16.13
52-Week Range ($) 0.026 - 0.026
Shares Outstanding (Mil) 1,193.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syntara Ltd Filings

Filing Date Document Date Form
No Filing Data

Syntara Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Syntara Ltd Frequently Asked Questions

What is Syntara Ltd(PMXSF)'s stock price today?
The current price of PMXSF is $0.03. The 52 week high of PMXSF is $0.03 and 52 week low is $0.03.
When is next earnings date of Syntara Ltd(PMXSF)?
The next earnings date of Syntara Ltd(PMXSF) is .
Does Syntara Ltd(PMXSF) pay dividends? If so, how much?
Syntara Ltd(PMXSF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1